2025 annual financial data
Tarsus Pharmaceuticals 2025 Revenue growth
Direct answer
Revenue growth was 146.71%.
Operating income was -70,969,000 USD and net income was -66,418,000 USD.
Operating cash flow was -12,451,000 USD.
Get free Tarsus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 451,360,000 USD
- Operating income
- -70,969,000 USD
- Net income
- -66,418,000 USD
- Operating cash flow
- -12,451,000 USD